Skip to main content
. Author manuscript; available in PMC: 2008 Sep 30.
Published in final edited form as: Biochemistry. 2007 Jun 20;46(28):8392–8400. doi: 10.1021/bi700289k

Figure 7. Heparin binding activity of unmodified and acrolein-modified apoE3-NT.

Figure 7

Unmodified (Panel A) or acrolein-modified (Panel B) apoE3-NT (100 μg) was loaded onto a heparin-Sepharose column in 20 mM sodium phosphate pH 7.4 in a ÄKTA FPLC system. The flow rate was maintained at 0.5 ml/min. A salt gradient consisting of 0-1 M NaCl was applied (black straight line) and the elution of the protein monitored at 280 nm. The black arrow represents the time at which the gradient was initiated.

HHS Vulnerability Disclosure